The cell surface hyaluronidase TMEM2 is essential for systemic hyaluronan catabolism and turnover

Tobisawa Y, Fujita N, Yamamoto H, Ohyama C, Irie F, Yamaguchi Y.

JBC   2021.11

Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer

Miura H, Yamamoto H, Okuyama Y, Ishi N, Tanaka R, Oishi T, Yoneyama F, Hamaya T, Togashi K, Fujita N, Okamoto T, Ohyama C, Hatakeyama S.

cancer med   2024.12

Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level

Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C.

Prostate.   2021.12

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

PLoS One.   2023.2

Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution.

T Koie, C Ohyama, H Yamamoto, S Hatakeyama, S Kudoh, T Yoneyama, Y Hashimoto, N Kamimura

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   38 ( 11 )   1101 - 1105   2012.11

Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study)

Kojima T, Kato R, Sazuka T, Yamamoto H, Fukuda S, Yamana K, Nakaigawa N, Sugino Y, Hamamoto S, Ito H, Murakami H, Obara W.

Observational Study   2022.11

Association between sex hormones and erectile dysfunction in men without hypoandrogenism

Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Mikami T, Itoh K, Ohyama C, Hatakeyama S.

Sci Rep .   2024.6

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

World J Mens Health.   2023.10

Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab

Tomoko Hamaya 1, Shingo Hatakeyama 2, Tohru Yoneyama 3, Yuki Tobisawa 1, Hirotake Kodama 1, Takeshi Fujita 4, Reiichi Murakami 4, Kazuyuki Mori 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 5, Yasuhiro Hashimoto 1, Hisao Saitoh 6, Shunji Narumi 7, Hirofumi Tomita 4, Chikara Ohyama

Science report   2023.9

Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study

Yoshiharu Okuyama 1, Shingo Hatakeyama 2, Ryuji Tabata 3, Daiji Fujimori 3, Yohei Kawashima 3, Toshikazu Tanaka 4, Naoki Fujita 1, Teppei Okamoto 1, Kazuyuki Mori 1, Hayato Yamamoto 1, Takahiro Yoneyama 5, Yasuhiro Hashimoto 1, Toshimitsu Matsuoka 6, Satoshi Sato 3, Chikara Ohyama 1

Int J urology   2023.8

Trends in the age of hospitalized patients with urological cancers: A 17-year experience

Noritaka Ishii 1, Shingo Hatakeyama 2, Hikari Miura 1, Ryuma Tanaka 1, Takuya Oishi 1, Hirotaka Horiguchi 1, Shogo Hosogoe 1, Naoki Fujita 1, Hiromichi Iwamura 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 3, Yasuhiro Hashimoto 1, Chikara Ohyama

int. J urology   2023.7

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy

Takuya Oishi 1, Shingo Hatakeyama 2, Ryuji Tabata 3, Daiji Fujimori 3, Mamoru Fukuda 3, Tetsuo Shinozaki 3, Noritaka Ishii 1, Hiromichi Iwamura 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 4, Yasuhiro Hashimoto 1, Satoshi Sato 3, Chikara Ohyama

Sci Rep.   2023.5

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction

Hikari Miura 1, Shingo Hatakeyama 2, Toshikazu Tanaka 3, Naoki Fujita 1, Hirotaka Horiguchi 1, Ryuma Tanaka 1, Daisuke Noro 4, Noriko Tokui 5, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 6, Yasuhiro Hashimoto 1, Chikara Ohyama

Urol Oncorogy   2023.5

Relationship between lower urinary tract symptoms and frailty

Yusuke Ozaki , Shingo Hatakeyama , Atsushi Imai , Jung Songee , Osamu Soma , Kai Ozaki , Naoki Fujita , Teppei Okamoto , Hiromichi Iwamura , Hayato Yamamoto , Takahiro Yoneyama , Yasuhiro Hashimoto , Chikara Ohyama

int. J urology   2023.4

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

World J Mens Health.   2023.4

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C.

Multicenter Study   2023.2

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study

Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Transl Androl Urol .   2023.2

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study

Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

World J Mens Health   2023.1

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study

Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.

World J Urol.   2023.1

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Urol Oncol   2022.12

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis

Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

Andrology   2022.11

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma

2022.10

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

Sci Rep .   2022.8

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

World J Mens Health .   2022.4

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C.

Sci Rep.   2022.3

Renal metastasis of ovarian granulosa cell tumor

Kyo Togashi, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Masayuki Futagami, Chikara Ohyama

IJU Case Rep   2022.3

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.

Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C.

Urol Oncol.   2021.12

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.

Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C.

Urol Oncol   2021.12

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries

Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Sci Rep .   2021.11

Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era

Naito S, Kato T, Numakura K, Hatakeyama S, Koguchi T, Kandori S, Kawasaki Y, Adachi H, Kato R, Narita S, Yamamoto H, Ogawa S, Kawamura S, Obara W, Ito A, Nishiyama H, Kojima Y, Ohyama C, Habuchi T, Tsuchiya N.

Int J Clin Oncol .   2021.10

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.

Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C.

BJU Int.   2021.10

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years

Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Urol Oncol.   2021.10

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer

Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

World J Urol .   2021.9

Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era.

Naito S, Kato T, Numakura K, Hatakeyama S, Koguchi T, Kandori S, Kawasaki Y, Adachi H, Kato R, Narita S, Yamamoto H, Ogawa S, Kawamura S, Obara W, Ito A, Nishiyama H, Kojima Y, Ohyama C, Habuchi T, Tsuchiya N

International journal of clinical oncology   2021.6

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer

Hirotaka Horiguchi, Ohyama Chikara

Urologic oncology   2021.4

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C

Urologic oncology   39 ( 4 )   238.e9 - 238.e17   2021.4

Narrative review of urinary glycan biomarkers in prostate cancer

Shingo Hatakeyama , Tohru Yoneyama , Yuki Tobisawa, Hayato Yamamoto, Chikara Ohyama

Transl Androl Urol   2021.4

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma

Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Urol Oncol   2021.4

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

World journal of urology   2021.3

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   39 ( 3 )   847 - 853   2021.3

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 3 )   194.e9 - 194.e16   2021.3

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project

Sakae Konishi, Ohyama Chikara

Urolodia internationalis   2021.3

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy

Fujita Naoki

Urologic oncology   2021.3

Altered gut microbiome associated with overactive bladder and daily urinary urgency.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

World journal of urology   39 ( 3 )   847 - 853   2021.3

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   10 ( 3 )   1143 - 1151   2021.3

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 3 )   194.e9 - 194.e16   2021.3

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   191.e1 - 191.e8   2021.3

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.

Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 3 )   191.e9 - 191.e16   2021.3

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   192.e7 - 192.e14   2021.3

N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.

Kodama H, Yoneyama T, Tanaka T, Noro D, Tobisawa Y, Yamamoto H, Suto S, Hatakeyama S, Mori K, Yoneyama T, Hashimoto Y, Kakizaki I, Nakaji S, Ohyama C

Cancer medicine   10 ( 4 )   1297 - 1313   2021.2

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan

Sake Konishi, Ohyama Chikara

lower urinary tract symptoms   2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   39 ( 1 )   75.e9 - 75.e16   2021.1

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan

teppei okamoto, ohyama chikara

world journal of urology   2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   26 ( 1 )   199 - 206   2021.1

The cell surface hyaluronidase TMEM2 regulates cell adhesion and migration via degradation of hyaluronan at focal adhesion sites.

Irie F, Tobisawa Y, Murao A, Yamamoto H, Ohyama C, Yamaguchi Y

The Journal of biological chemistry   296   100481   2021.1

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

World journal of urology   39 ( 1 )   169 - 175   2021.1

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Lower urinary tract symptoms   13 ( 1 )   56 - 63   2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   39 ( 1 )   75.e9 - 75.e16   2021.1

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

Urologia internationalis   105 ( 3-4 )   232 - 239   2021

尿路結石形成に関与する糖鎖変異オステオポンチンの検索

阿南 剛, 橋本 安弘, 佐藤 信, 大山 力, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘

日本内分泌学会雑誌   97 ( 0 )   47 - 49   2021

RARCと回腸を利用した尿路変向術

米山 高弘, 畠山 真吾, 橋本 安弘, 大山 力, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人

Japanese Journal of Endourology   34 ( 1 )   24 - 32   2021

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study

Tanaka Toshikazu, Ohyama Chikara

international journal of urology   2020.12

Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.

Tanaka T, Hatakeyama S, Numakura K, Kido K, Noro D, Oikawa M, Hosogoe S, Tokui N, Yamamoto H, Narita S, Ito H, Yoneyama T, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 12 )   1095 - 1100   2020.12

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)

hamaya tomoko, Ohyama Chikara

International Journal of Clinical Oncology   2020.10

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Yasushi Mariya, Chikara Ohyama

Clinical genitourinary cancer   18 ( 5 )   e523 - e530   2020.10

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   38 ( 10 )   795.e9 - 795.e17   2020.10

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C

Clinical genitourinary cancer   18 ( 5 )   e523 - e530   2020.10

Geriatric 8 screening of frailty in patients with prostate cancer

masaki momota, chikara ohyama

international journal of urology   2020.8

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Urologic oncology   38 ( 8 )   684.e17 - 684.e24   2020.8

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan

teppei okamoto, ohyama chikara

International urological nephrology   2020.8

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   649 - 654   2020.8

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

International urology and nephrology   52 ( 8 )   1421 - 1428   2020.8

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.

Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   38 ( 8 )   684.e17 - 684.e24   2020.8

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

Urologic oncology   38 ( 8 )   684.e1 - 684.e8   2020.8

Geriatric 8 screening of frailty in patients with prostate cancer.

Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   642 - 648   2020.8

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer

itsuto hamano

IJU case report   2020.7

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   24 ( 7 )   638 - 645   2020.7

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, Reiichi Murakami, Tomoko Hamaya, Kyo Togashi, Yuichiro Suzuki, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Transplantation proceedings   52 ( 6 )   1723 - 1728   2020.7

Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.

Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C

Transplantation proceedings   52 ( 6 )   1723 - 1728   2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Hamano I, Hatakeyama S, Hamaya T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

IJU case reports   3 ( 4 )   141 - 144   2020.7

Survey on attitudes toward brain-dead and living donor transplantation in medical students: a cross-sectional study in Japan.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Saitoh H, Suzuki T, Tomita H, Ohyama C

Clinical and experimental nephrology   24 ( 7 )   638 - 645   2020.7

Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.

Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C

Transplantation proceedings   52 ( 6 )   1700 - 1704   2020.7

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics   39 ( 5 )   1567 - 1575   2020.6

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan.

Okamoto T, Hatakeyama S, Ando M, Songee J, Imai A, Hamano I, Fujita N, Okamoto A, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

Neurourology and urodynamics   39 ( 5 )   1567 - 1575   2020.6

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults

osamu soma, ohyama chikara

lower urinary tract symptoms   2020.5

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

Lower urinary tract symptoms   12 ( 2 )   128 - 136   2020.5

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Okita K, Hatakeyama S, Imai A, Tanaka T, Hamano I, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Nakaji S, Suzuki T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   344 - 349   2020.4

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

World journal of urology   2020.3

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

International urology and nephrology   2020.3

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   2020.3

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Suppanuntaroek S, Hatakeyama S, Fujita N, Kubota Y, Suzuki Y, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Mori K, Imai A, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績

米山 高弘, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人

Japanese Journal of Endourology   33 ( 2 )   325 - 329   2020

In-match physical demands on elite Japanese rugby union players using a global positioning system.

Yamamoto H, Takemura M, Iguchi J, Tachibana M, Tsujita J, Hojo T

BMJ open sport & exercise medicine   6 ( 1 )   e000659   2020

Application of carbon dioxide to the skin and muscle oxygenation of human lower-limb muscle sites during cold water immersion.

Yoshimura M, Hojo T, Yamamoto H, Tachibana M, Nakamura M, Tsutsumi H, Fukuoka Y

PeerJ   8   e9785   2020

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama

International journal of molecular sciences   21 ( 1 )   2019.12

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.

Anan G, Yoneyama T, Noro D, Tobisawa Y, Hatakeyama S, Sutoh Yoneyama M, Yamamoto H, Imai A, Iwamura H, Kohada Y, Mikami J, Ito J, Kaiho Y, Yoneyama T, Hashimoto Y, Sato M, Ohyama C

International journal of molecular sciences   21 ( 1 )   2019.12

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

The journal of sexual medicine   16 ( 12 )   1922 - 1929   2019.12

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.

Okamoto T, Hatakeyama S, Imai A, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

The journal of sexual medicine   16 ( 12 )   1922 - 1929   2019.12

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama

Scientific reports   9 ( 1 )   16761 - 16761   2019.11

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.

Matsumoto T, Hatakeyama S, Yoneyama T, Tobisawa Y, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ito H, Nishimura SI, Ohyama C

Scientific reports   9 ( 1 )   16761   2019.11

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Koichi Kido, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

European urology focus   5 ( 6 )   1120 - 1126   2019.11

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

European urology focus   5 ( 6 )   1120 - 1126   2019.11

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Momota M, Hatakeyama S, Tokui N, Sato T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narita S, Kawaguchi T, Ohyama C

European urology focus   5 ( 6 )   1066 - 1073   2019.11

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms   2019.10

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   26 ( 10 )   992 - 998   2019.10

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Hamano I, Fujita N, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   26 ( 10 )   992 - 998   2019.10

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Konishi S, Hatakeyama S, Numakura K, Narita S, Inoue T, Saito M, Tokui N, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Narita S, Kawaguchi T, Habuchi T, Ohyama C

Clinical genitourinary cancer   17 ( 5 )   e1080 - e1089   2019.10

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 10 )   88 - 88   2019.9

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C

Medical oncology (Northwood, London, England)   36 ( 10 )   88   2019.9

Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.

Sakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Noriko Tokui, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama

Clinical genitourinary cancer   17 ( 5 )   e1080 - e1089   2019.7

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports   2 ( 4 )   236 - 239   2019.7

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama

Clinical and experimental nephrology   23 ( 6 )   807 - 813   2019.6

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Teppei Matsumoto, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Kazuhisa Hagiwara, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Nakaji, Chikara Ohyama

BJU international   123 ( 5 )   877 - 884   2019.5

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

BJU international   123 ( 5 )   877 - 884   2019.5

TMEM2: A missing link in hyaluronan catabolism identified?

Yamaguchi Y, Yamamoto H, Tobisawa Y, Irie F

Matrix biology : journal of the International Society for Matrix Biology   78-79   139 - 146   2019.5

Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.

Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C.

Clin Exp Nephrol.   23 ( 6 )   807 - 813   2019.2

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Okita K, Hatakeyama S, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

Clin Genitourin Cancer   17 ( 3 )   e440 - e446   2019.1

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.

Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Clinical genitourinary cancer   17 ( 3 )   e440 - e446   2019.1

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Koie T, Ohyama C, Yoneyama T, Nagasaka H, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y.

The International Journal of Medical Robotics + Computer Assisted Surgery   2018.12

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

European urology focus   4 ( 6 )   946 - 953   2018.12

Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.

Koie T, Ohyama C, Yoneyama T, Nagasaka H, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y

The international journal of medical robotics + computer assisted surgery : MRCAS   14 ( 6 )   e1955   2018.12

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C.

Medical Oncology   2018.11

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Naoki Fujita, Sakae Konishi, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Kazuaki Yoshikawa, Takuya Koie, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 1 )   7 - 7   2018.11

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C

Medical oncology (Northwood, London, England)   36 ( 1 )   7   2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C

Medical Oncology   2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Sakae Konishi, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Medical oncology (Northwood, London, England)   36 ( 1 )   6 - 6   2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C

Medical oncology (Northwood, London, England)   36 ( 1 )   6   2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C.

International Urology and Nephrology   2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology   50 ( 11 )   1999 - 2005   2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.

Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C

International urology and nephrology   50 ( 11 )   1999 - 2005   2018.11

Can single positive core prostate cancer at biopsy be considered a low-risk disease?

Yamamoto H, Koie T, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Kawamura S, Kato T, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C.

International Urology and Nephrology   2018.10

Can single positive core prostate cancer at biopsy be considered a low-risk disease?

Yamamoto H, Koie T, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Kawamura S, Kato T, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C

International urology and nephrology   50 ( 10 )   1829 - 1833   2018.10

Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.

Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S, Okita K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

BJU international   2018.9

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Hamano I, Hatakeyama S, Nakamura R, Fukuhara R, Noro D, Tanaka T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Yokoyama Y, Ohyama C.

international journal of urology   2018.9

Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.

Hamano I, Hatakeyama S, Nakamura R, Fukuhara R, Noro D, Tanaka T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Yokoyama Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   25 ( 9 )   817 - 824   2018.9

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.

International clinical oncology   2018.8

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.

International jorunal of clinical oncology   2018.8

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Kido K, Hatakeyama S, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C

International journal of clinical oncology   23 ( 4 )   726 - 733   2018.8

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Momota M, Hatakeyama S, Tokui N, Sato T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narita S, Kawaguchi T, Ohyama C.

Europian urology focus   2018.5

Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.

Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.

Europian urology focus   2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Momota M, Hatakeyama S, Yamamoto H, Iwamura H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C.

oncotarget   2018.5

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Momota M, Hatakeyama S, Yamamoto H, Iwamura H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Iwabuchi I, Ogasawara M, Kawaguchi T, Ohyama C

Oncotarget   9 ( 33 )   23047 - 23057   2018.5

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C.

oncotarget   2018.4

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

Oncotarget   9 ( 25 )   17396 - 17405   2018.4

Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.

Oikawa M, Hatakeyama S, Yoneyma T, Tobisawa Y, Narita T, Yamamoto H, Hashimoto Y, Koie T, Narita S, Sasaki A, Tsuchiya N, Habuchi T, Takahashi I, Nakaji S, Ohyama C

European urology focus   4 ( 3 )   405 - 411   2018.4

The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Masaki Momota, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

European urology focus   2018.3

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Hirotaka Horiguchi, Takahiro Yoneyama, Shingo Hatakeyama, Noriko Tokui, Tendo Sato, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   35 ( 4 )   41 - 41   2018.2

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy.

Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C

Medical oncology (Northwood, London, England)   35 ( 4 )   41   2018.2

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology   2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Hirotaka Horiguchi, Shingo Hatakeyama, Go Anan, Yuka Kubota, Hirotake Kodama, Masaki Momota, Koichi Kido, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   9 ( 9 )   8746 - 8755   2018.2

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.

Horiguchi H, Hatakeyama S, Anan G, Kubota Y, Kodama H, Momota M, Kido K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Sato M, Ohyama C

Oncotarget   9 ( 9 )   8746 - 8755   2018.2

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.

Daisuke Noro, Takuya Koie, Yasuhiro Hashimoto, Toshikazu Tanaka, Chikara Ohyama, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Shingo Hatakeyama, Hayato Yamamoto, Masato Kitayama, Kazuyoshi Hirota

Japanese journal of clinical oncology   48 ( 2 )   184 - 189   2018.2

Significance of preoperative butyrylcholinesterase level as an independent predictor of survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy.

Noro D, Koie T, Hashimoto Y, Tanaka T, Ohyama C, Tobisawa Y, Yoneyama T, Imai A, Hatakeyama S, Yamamoto H, Kitayama M, Hirota K

Japanese journal of clinical oncology   48 ( 2 )   184 - 189   2018.2

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   23 ( 1 )   134 - 141   2018.2

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.

Tanaka Y, Hatakeyama S, Hosogoe S, Tanaka T, Hamano I, Kusaka A, Iwamura H, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   23 ( 1 )   134 - 141   2018.2

Slow Progression of Aortic Calcification Is a Potential Benefit of Pre-emptive Kidney Transplantation.

H Mursawa, S Hatakeyama, H Yamamoto, Y Tanaka, O Soma, T Matsumoto, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Suzuki, S Narumi, C Ohyama

Transplantation proceedings   50 ( 1 )   145 - 149   2018.1

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation.

Kodama H, Hatakeyama S, Matsumoto T, Tanaka T, Horiguchi H, Kubota Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

Case reports in urology   2018   6904827   2018

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Toshikazu Tanaka, Tohru Yoneyama, Daisuke Noro, Kengo Imanishi, Yuta Kojima, Shingo Hatakeyama, Yuki Tobisawa, Kazuyuki Mori, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Masakazu Tanaka, Shin-Ichiro Nishimura, Shizuka Kurauchi, Ippei Takahashi, Chikara Ohyama

International journal of molecular sciences   18 ( 12 )   2017.12

Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.

Tanaka T, Yoneyama T, Noro D, Imanishi K, Kojima Y, Hatakeyama S, Tobisawa Y, Mori K, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Tanaka M, Nishimura SI, Kurauchi S, Takahashi I, Ohyama C

International journal of molecular sciences   18 ( 12 )   2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Naoki Fujita, Takuya Koie, Chikara Ohyama, Yoshimi Tanaka, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Yuki Tobisawa, Tohru Yoneyama, Shingo Hatakeyama, Yasuhiro Hashimoto

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017.12

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.

Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017.12

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Yuka Kubota, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hiromichi Iwamura, Jotaro Mikami, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 60 )   101500 - 101508   2017.11

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.

Kubota Y, Hatakeyama S, Tanaka T, Fujita N, Iwamura H, Mikami J, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C

Oncotarget   8 ( 60 )   101500 - 101508   2017.11

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Toshikazu Tanaka, Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Atsushi Imai, Yuki Tobisawa, Shingo Hatakeyama, Hayato Yamamoto, Tohru Yoneyama, Hirotaka Horiguchi, Hirotake Kodama, Takahiro Yoneyama

Japanese journal of clinical oncology   47 ( 11 )   1078 - 1082   2017.11

Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy.

Tanaka T, Koie T, Ohyama C, Hashimoto Y, Imai A, Tobisawa Y, Hatakeyama S, Yamamoto H, Yoneyama T, Horiguchi H, Kodama H, Yoneyama T

Japanese journal of clinical oncology   47 ( 11 )   1078 - 1082   2017.11

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 49 )   86130 - 86142   2017.10

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.

Anan G, Hatakeyama S, Fujita N, Iwamura H, Tanaka T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Sato M, Ohyama C

Oncotarget   8 ( 49 )   86130 - 86142   2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Hirotake Kodama, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Go Anan, Ken Fukushi, Takuma Narita, Toshikazu Tanaka, Yuka Kubota, Hirotaka Horiguchi, Masaki Momota, Koichi Kido, Teppei Matsumoto, Osamu Soma, Itsuto Hamano, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Atsushi Sasaki, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   8 ( 47 )   83183 - 83194   2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C

Oncotarget   8 ( 47 )   83183 - 83194   2017.10

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 37 )   61404 - 61414   2017.9

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.

Hamano I, Hatakeyama S, Iwamurau H, Fujita N, Fukushi K, Narita T, Hagiwara K, Kusaka A, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Oncotarget   8 ( 37 )   61404 - 61414   2017.9

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Oncotarget   8 ( 39 )   65492 - 65505   2017.9

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.

Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Oncotarget   8 ( 39 )   65492 - 65505   2017.9

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Takuma Narita, Shingo Hatakeyama, Takuya Koie, Shogo Hosogoe, Teppei Matsumoto, Osamu Soma, Hayato Yamamoto, Tohru Yoneyama, Yuki Tobisawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BMC urology   17 ( 1 )   72 - 72   2017.8

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction.

Narita T, Hatakeyama S, Koie T, Hosogoe S, Matsumoto T, Soma O, Yamamoto H, Yoneyama T, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C

BMC urology   17 ( 1 )   72   2017.8

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Yoshimi Tanaka, Kazuhisa Hagiwara, Hideaki Hirai, Satoko Morohashi, Hiroshi Kijima, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Oncotarget   8 ( 30 )   49749 - 49756   2017.7

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.

Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Tanaka Y, Hagiwara K, Hirai H, Morohashi S, Kijima H, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

Oncotarget   8 ( 30 )   49749 - 49756   2017.7

A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase.

Hayato Yamamoto, Yuki Tobisawa, Toshihiro Inubushi, Fumitoshi Irie, Chikara Ohyama, Yu Yamaguchi

The Journal of biological chemistry   292 ( 18 )   7304 - 7313   2017.5

A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase.

Yamamoto H, Tobisawa Y, Inubushi T, Irie F, Ohyama C, Yamaguchi Y

The Journal of biological chemistry   292 ( 18 )   7304 - 7313   2017.5

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Kazuhisa Hagiwara, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Yuki Tobisawa, Tohru Yoneyama

International urology and nephrology   49 ( 5 )   811 - 816   2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

Medical oncology (Northwood, London, England)   34 ( 5 )   90 - 90   2017.5

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   24 ( 5 )   361 - 366   2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.

Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

Medical oncology (Northwood, London, England)   34 ( 5 )   90   2017.5

Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.

Hagiwara K, Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Tobisawa Y, Yoneyama T

International urology and nephrology   49 ( 5 )   811 - 816   2017.5

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.

Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   24 ( 5 )   361 - 366   2017.5

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

European urology focus   2017.4

Clinical relevance of aortic calcification in urolithiasis patients.

Toshikazu Tanaka, Shingo Hatakeyama, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   25 - 25   2017.4

Clinical relevance of aortic calcification in urolithiasis patients.

Tanaka T, Hatakeyama S, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

BMC urology   17 ( 1 )   25   2017.4

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   22 ( 2 )   366 - 372   2017.4

Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Takuma Narita, Shingo Hatakeyama, Tohru Yoneyama, Shintaro Narita, Shinichi Yamashita, Koji Mitsuzuka, Toshihiko Sakurai, Sadafumi Kawamura, Tatsuo Tochigi, Ippei Takahashi, Shigeyuki Nakaji, Yuki Tobisawa, Hayato Yamamoto, Takuya Koie, Norihiko Tsuchiya, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama

Cancer medicine   6 ( 4 )   739 - 748   2017.4

Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.

Narita T, Hatakeyama S, Yoneyama T, Narita S, Yamashita S, Mitsuzuka K, Sakurai T, Kawamura S, Tochigi T, Takahashi I, Nakaji S, Tobisawa Y, Yamamoto H, Koie T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C

Cancer medicine   6 ( 4 )   739 - 748   2017.4

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.

Fukushi K, Narita T, Hatakeyama S, Yamamoto H, Soma O, Matsumoto T, Tobisawa Y, Yoneyama T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   22 ( 2 )   366 - 372   2017.4

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani

Japanese journal of clinical oncology   47 ( 3 )   252 - 256   2017.3

The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Yamauchi A, Shimazui T, Ohtani M

Japanese journal of clinical oncology   47 ( 3 )   252 - 256   2017.3

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

BMC urology   17 ( 1 )   13 - 13   2017.2

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.

Fukushi K, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Soma O, Matsumoto T, Hamano I, Narita T, Imai A, Yoneyama T, Hashimoto Y, Koie T, Terayama Y, Funyu T, Ohyama C

BMC urology   17 ( 1 )   13   2017.2

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

Murasawa H, Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Iwabuchi I, Ogasawara M, Kawaguchi T

International journal of clinical oncology   22 ( 1 )   159 - 165   2017.2

The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C

Medical oncology (Northwood, London, England)   34 ( 1 )   1   2017.1

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Yoshimi Tanaka, Shingo Hatakeyama, Toshikazu Tanaka, Hayato Yamamoto, Takuma Narita, Itsuto Hamano, Teppei Matsumoto, Osamu Soma, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ippei Takahashi, Shigeyuki Nakaji, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama

PloS one   12 ( 7 )   e0182136 - e0182136   2017

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

PloS one   12 ( 7 )   e0182136   2017

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.

Fujita N, Hatakeyama S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nigawara T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   23 ( 5 )   412 - 7   2016.5

Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.

Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K

International journal of clinical oncology   21 ( 2 )   379 - 383   2016.4

Core 2 β-1, 6-N-acetylglucosaminyltransferase-1 expression in prostate biopsy specimen is an indicator of prostate cancer aggressiveness.

Sato T, Yoneyama T, Tobisawa Y, Hatakeyama S, Yamamoto H, Kojima Y, Mikami J, Mori K, Hashimoto Y, Koie T, Ohyama C

Biochemical and biophysical research communications   470 ( 1 )   150 - 156   2016.1

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.

Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

PloS one   11 ( 3 )   e0151742   2016

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.

Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C

PloS one   11 ( 5 )   e0153961   2016

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.

Hamano I, Hatakeyama S, Yoneyama T, Tobisawa Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

SpringerPlus   5 ( 1 )   1917   2016

Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].

Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

PloS one   11 ( 2 )   e0149544   2016

Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.

Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K

International urology and nephrology   47 ( 9 )   1509 - 14   2015.9

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.

Koie T, Ohyama C, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K

BMC urology   15   32   2015.4

Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.

Yoneyama T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C

International journal of clinical oncology   20 ( 2 )   369 - 74   2015.4

Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y

Medical oncology (Northwood, London, England)   32 ( 1 )   421   2015.1

A case of primary renal carcinoid tumor.

Tanaka T, Yamamoto H, Imai A, Shingo H, Yoneyama T, Koie T, Hashimoto Y, Ohyama C

Case reports in urology   2015   736213   2015

[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].

Noro D, Yoneyama T, Hagiwara K, Mori K, Yamamoto H, Hashimoto Y, Koie T, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   60 ( 11 )   579 - 82   2014.11

Testicular metastasis of prostate cancer: a case report.

Kusaka A, Koie T, Yamamoto H, Hamano I, Yoneyama T, Hashimoto Y, Ohyama C, Tobisawa Y, Yoneyama T

Case reports in oncology   7 ( 3 )   643 - 7   2014.9

Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.

Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Kitayam M, Hirota K

Urologic oncology   32 ( 6 )   820 - 5   2014.8

Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cells.

Imanishi K, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S

Molecular medicine reports   9 ( 6 )   2159 - 65   2014.6

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y

Medical oncology (Northwood, London, England)   31 ( 5 )   949   2014.5

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.

Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y

World journal of surgical oncology   12   134   2014.4

Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.

Tokui N, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S

Molecular medicine reports   9 ( 4 )   1142 - 6   2014.4

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.

Iwamura H, Hatakeyama S, Tanaka Y, Tanaka T, Tokui N, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Ohyama C

BMC research notes   7   64   2014.1

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.

Narita T, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto T, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C, Hakamada K

Case reports in oncology   7 ( 1 )   233 - 8   2014.1

A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.

Hagiwara K, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

Case reports in urology   2014   646743   2014

Nonfunctioning adrenal tumor

Yamamoto Hayato

Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery   31 ( 3 )   180 - 183   2014

Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy.

Koie T, Ohyama C, Mikami J, Iwamura H, Fujita N, Sato T, Kojima Y, Fukushi K, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Kitayama M, Hirota K

TheScientificWorldJournal   2014   948305   2014

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.

Koie T, Ohyama C, Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y

BMC research notes   6   484   2013.11

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura

International journal of clinical oncology   18 ( 4 )   724 - 730   2013.8

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.

Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, Kamimura N

International journal of clinical oncology   18 ( 4 )   724 - 30   2013.8

[Ureteral endometriosis treated by hormonal therapy : a case report].

Jotaro Mikami, Hayato Yamamoto, Akiko Okamoto, Hirofumi Ishimura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   431 - 434   2013.7

In vivo selection of high-metastatic subline of bladder cancer cell and its characterization.

Naoki Sugiyama, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Hayato Yamamoto, Akiko Okamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Takamitsu Inoue, Tomonori Habuchi, Chikara Ohyama, Shigeru Tsuboi

Oncology research   20 ( 7 )   289 - 295   2013.7

[Successful control of hyper-cortisolemia due to ACTH-producing thyroid carcinoid by laparoscopic bilateral adrenalectomy : a case report].

Yuta Kojima, Noritaka Kamimura, Hayato Yamamoto, Hiromi Murasawa, Akiko Okamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   419 - 422   2013.7

[Successful control of hyper-cortisolemia due to ACTH-producing thyroid carcinoid by laparoscopic bilateral adrenalectomy : a case report].

Kojima Y, Kamimura N, Yamamoto H, Murasawa H, Okamoto A, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   419 - 22   2013.7

[Ureteral endometriosis treated by hormonal therapy : a case report].

Mikami J, Yamamoto H, Okamoto A, Ishimura H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   431 - 4   2013.7

[Paget's disease mimicking metastatic prostate cancer on bone scan image : a case report].

Fukushi K, Koie T, Yamamoto H, Okamoto A, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   59 ( 4 )   247 - 50   2013.4

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.

Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Hayato Yamamoto, Kengo Imanishi, Teppei Okamoto, Noriko Tokui, Naoki Sugiyama, Yuichiro Suzuki, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Michiko N Fukuda, Chikara Ohyama

Transplantation   95 ( 3 )   418 - 425   2013.2

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.

Yoneyama T, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda MN, Ohyama C

Transplantation   95 ( 3 )   418 - 25   2013.2

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.

Teppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, Kazuyuki Mori, Hayato Yamamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Minoru Fukuda, Chikara Ohyama, Shigeru Tsuboi

Molecular medicine reports   7 ( 2 )   359 - 364   2013.2

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.

Okamoto T, Yoneyama MS, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C, Tsuboi S

Molecular medicine reports   7 ( 2 )   359 - 64   2013.2

ADULT MATURE TERATOMA OF THE TESTIS : A CASE REPORT

59 ( 1 )   57 - 60   2013.1

[Adult mature teratoma of the testis: a case report].

Imanishi K, Hatakeyama S, Okamoto T, Suzuki Y, Sugiyama N, Yamamoto H, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   59 ( 1 )   57 - 60   2013.1

Blood Group Antigen Targeting Peptide Suppresses Thrombotic Microangiopathy in Renal Glomerular Capillaries after ABO-Incompatible Blood Reperfusion

Yoneyama Tohru, Hatakeyama Shingo, Ymamoto Hayato, Imanishi Kengo, Okamoto Teppei, Tokui Noriko, Sugiyama Naoki, Suzuki Yuichiro, Kudo Shigemasa, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Fukuda Michiko N., Ohyama Chikara

弘前医学   64 ( 0 )   S121 - 128   2013

In vivo selection of high-metastatic subline of bladder cancer cell and its characterization.

Sugiyama N, Yoneyama MS, Hatakeyama S, Yamamoto H, Okamoto A, Koie T, Saitoh H, Yamaya K, Funyu T, Inoue T, Habuchi T, Ohyama C, Tsuboi S

Oncology research   20 ( 7 )   289 - 95   2013

Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.

T Koie, C Ohyama, H Yamamoto, S Hatakeyama, T Yoneyama, Y Hashimoto, N Kamimura

Prostate cancer and prostatic diseases   15 ( 4 )   397 - 401   2012.12

MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.

Yuichiro Suzuki, Mihoko Sutoh, Shingo Hatakeyama, Kazuyuki Mori, Hayato Yamamoto, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Tomonori Habuchi, Yoichi Arai, Minoru Fukuda, Chikara Ohyama, Shigeru Tsuboi

International journal of oncology   40 ( 6 )   1831 - 1838   2012.6

Sarcoidosis of the ureter.

Yasuhiro Hashimoto, Shigemasa Kudoh, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Chikara Ohyama

Urology   79 ( 6 )   e81 - e82   2012.6

MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.

Suzuki Y, Sutoh M, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Habuchi T, Arai Y, Fukuda M, Ohyama C, Tsuboi S

International journal of oncology   40 ( 6 )   1831 - 8   2012.6

Sarcoidosis of the ureter.

Hashimoto Y, Kudoh S, Yamamoto H, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C

Urology   79 ( 6 )   e81 - 2   2012.6

Skin perfusion pressure is a prognostic factor in hemodialysis patients.

Shingo Hatakeyama, Masaaki Saito, Kumiko Ishigaki, Hayato Yamamoto, Akiko Okamoto, Yusuke Ishibashi, Hiromi Murasawa, Kengo Imanishi, Noriko Tokui, Teppei Okamoto, Yuichiro Suzuki, Naoki Sugiyama, Atsushi Imai, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kaminura, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

International journal of nephrology   2012   385274 - 385274   2012.4

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.

Shingo Hatakeyama, Hayato Yamamoto, Akiko Okamoto, Kengo Imanishi, Noriko Tokui, Teppei Okamoto, Yuichiro Suzuki, Naoaki Sugiyama, Atsushi Imai, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kaminura, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

International journal of nephrology   2012   376128 - 376128   2012.1

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.

Hatakeyama S, Yamamoto H, Okamoto A, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C

International journal of nephrology   2012   376128   2012

Skin perfusion pressure is a prognostic factor in hemodialysis patients.

Hatakeyama S, Saito M, Ishigaki K, Yamamoto H, Okamoto A, Ishibashi Y, Murasawa H, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C

International journal of nephrology   2012   385274   2012

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.

Shingo Hatakeyama, Terumasa Toikawa, Akiko Okamoto, Hayato Yamamoto, Kengo Imanishi, Teppei Okamoto, Noriko Tokui, Yuichiro Suzuki, Naoki Sugiyama, Atsushi Imai, Yasuhiro Hashimoto, Shigemasa Kudo, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama

International journal of nephrology   2011   464735 - 464735   2011.11

An aggressive signet ring cell carcinoma of the prostate in a Japanese man.

Hashimoto Y, Imanishi K, Okamoto A, Sasaki A, Saitoh H, Wada R, Yamamoto H, Koie T, Ohyama C

Case reports in oncology   4 ( 3 )   517 - 20   2011.9

Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.

Hayato Yamamoto, Mihoko Sutoh, Shingo Hatakeyama, Yasuhiro Hashimoto, Takahiro Yoneyama, Takuya Koie, Hisao Saitoh, Kanemitsu Yamaya, Tomihisa Funyu, Toshiya Nakamura, Chikara Ohyama, Shigeru Tsuboi

The Journal of urology   185 ( 5 )   1930 - 1938   2011.5

Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.

Yamamoto H, Sutoh M, Hatakeyama S, Hashimoto Y, Yoneyama T, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S

The Journal of urology   185 ( 5 )   1930 - 8   2011.5

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.

Hatakeyama S, Toikawa T, Okamoto A, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Suzuki Y, Sugiyama N, Imai A, Hashimoto Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Saitoh H, Funyu T, Ohyama C

International journal of nephrology   2011   464735   2011

PP-213 膀胱癌の浸潤能に関与するinvadopodia形成にはformin-binding protein 17が必須である(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

山本 勇人, 米山 高弘, 古家 琢也, 神村 典孝, 大山 力, 吉川 和曉, 須藤 美穂子, 橋本 安弘, 坪井 滋, 山谷 金光, 齋藤 久夫, 舟生 富壽, 畠山 真吾

日本泌尿器科学会雑誌   102 ( 2 )   2011

PP-040 膀胱癌細胞における浸潤能と浸潤突起の形成について(発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

須藤 美穂子, 中村 敏也, 佐藤 達資, 大山 力, 坪井 滋, 橋本 安弘, 米山 高弘, 山本 勇人, 畠山 真吾, 古家 琢也, 山谷 金光, 齋藤 久夫, 舟生 富寿

日本泌尿器科学会雑誌   102 ( 2 )   2011

[Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].

Ikuya Iwabuchi, Kazuyuki Mori, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Tadashi Suzuki, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   56 ( 10 )   551 - 557   2010.10

[The giant schwannoma in the pelvic cavity: a case report].

Yuichiro Suzuki, Naoki Sugiyama, Akiko Okamoto, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hasimoto, Takuya Koie, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   56 ( 10 )   581 - 583   2010.10

[Experience of laparoscopic surgery of pheochromocytoma found on induction for hemodialysis].

Naoki Sugiyama, Yuichiro Suzuki, Akiko Okamoto, Hayato Yamamoto, Shigemasa Kudo, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   56 ( 10 )   565 - 567   2010.10

[Experience of laparoscopic surgery of pheochromocytoma found on induction for hemodialysis].

Sugiyama N, Suzuki Y, Okamoto A, Yamamoto H, Kudo S, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   56 ( 10 )   565 - 7   2010.10

[The giant schwannoma in the pelvic cavity: a case report].

Suzuki Y, Sugiyama N, Okamoto A, Yamamoto H, Hatakeyama S, Yoneyama T, Hasimoto Y, Koie T, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   56 ( 10 )   581 - 3   2010.10

[Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].

Iwabuchi I, Mori K, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Suzuki T, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   56 ( 10 )   551 - 7   2010.10

Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.

Shingo Hatakeyama, Atsushi Kyan, Hayato Yamamoto, Akiko Okamoto, Naoki Sugiyama, Yuichiro Suzuki, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shigeyuki Yamada, Hideo Saito, Yoichi Arai, Minoru Fukuda, Chikara Ohyama

International journal of cancer. Journal international du cancer   127 ( 5 )   1052 - 1059   2010.9

Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.

Hatakeyama S, Kyan A, Yamamoto H, Okamoto A, Sugiyama N, Suzuki Y, Yoneyama T, Hashimoto Y, Koie T, Yamada S, Saito H, Arai Y, Fukuda M, Ohyama C

International journal of cancer   127 ( 5 )   1052 - 9   2010.9

Risk factors for erectile dysfunction in healthy Japanese men.

Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Ikuya Iwabuchi, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Kazuma Danjyo, Chikara Ohyama

International journal of andrology   33 ( 4 )   569 - 573   2010.8

Risk factors for erectile dysfunction in healthy Japanese men.

Imai A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Danjyo K, Ohyama C

International journal of andrology   33 ( 4 )   569 - 73   2010.8

A case of adrenocortical oncocytoma occurring with aldosteronoma.

Ken Terui, Satoru Sakihara, Kazunori Kageyama, Takeshi Nigawara, Shinobu Takayasu, Yuki Matsuhashi, Akihito Kon, Hayato Yamamoto, Chikara Ohyama, Hironobu Sasano, Toshihiro Suda

The Journal of clinical endocrinology and metabolism   95 ( 8 )   3597 - 3598   2010.8

A case of adrenocortical oncocytoma occurring with aldosteronoma.

Terui K, Sakihara S, Kageyama K, Nigawara T, Takayasu S, Matsuhashi Y, Kon A, Yamamoto H, Ohyama C, Sasano H, Suda T

The Journal of clinical endocrinology and metabolism   95 ( 8 )   3597 - 8   2010.8

Cauda equina symptoms are closely related to male lower urinary tract symptoms.

Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Ikuya Iwabuchi, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Kazuma Danjo, Atsushi Ono, Chikara Ohyama

Urologia internationalis   84 ( 3 )   325 - 329   2010.4

[Relationship between tumor volume and PSA recurrence after radical prostatectomy].

Yasuhiro Hashimoto, Akishi Momose, Akiko Okamoto, Hayato Yamamoto, Shingo Hatakeyama, Ikuya Iwabuchi, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   56 ( 2 )   91 - 94   2010.2

Invadopodia formation by bladder tumor cells.

Mihoko Sutoh, Yasuhiro Hashimoto, Takahiro Yoneyama, Hayato Yamamoto, Shingo Hatakeyama, Takuya Koie, Akiko Okamoto, Kanemitsu Yamaya, Hisao Saitoh, Tomihisa Funyu, Toshiya Nakamura, Tatsusuke Sato, Chikara Ohyama, Shigeru Tsuboi

Oncology research   19 ( 2 )   85 - 92   2010.2

[Relationship between tumor volume and PSA recurrence after radical prostatectomy].

Hashimoto Y, Momose A, Okamoto A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Koie T, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   56 ( 2 )   91 - 4   2010.2

Tumor formation assays.

Shingo Hatakeyama, Hayato Yamamoto, Chikara Ohyama

Methods in enzymology   479   397 - 411   2010.1

APP-016 糖鎖抗原類似ペプチドIF7を用いた効果的な癌特異的化学療法の開発(発表・討論,総会賞応募ポスター,第98回日本泌尿器科学総会)

畠山 真吾, 山本 勇人, 岡本 亜希子, 斉藤 久夫, 坪井 茂, 山谷 金光, 舟生 富寿, 大山 力, 福田 道子

日本泌尿器科学会雑誌   101 ( 2 )   2010

Tumor formation assays.

Hatakeyama S, Yamamoto H, Ohyama C

Methods in enzymology   479   397 - 411   2010

Invadopodia formation by bladder tumor cells.

Sutoh M, Hashimoto Y, Yoneyama T, Yamamoto H, Hatakeyama S, Koie T, Okamoto A, Yamaya K, Saitoh H, Funyu T, Nakamura T, Sato T, Ohyama C, Tsuboi S

Oncology research   19 ( 2 )   85 - 92   2010

Cauda equina symptoms are closely related to male lower urinary tract symptoms.

Imai A, Yamamoto H, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Danjo K, Ono A, Ohyama C

Urologia internationalis   84 ( 3 )   325 - 9   2010

APP-038 Core-2 N-acetylglucosaminyltransferase (C2GnT)-I遺伝子導入によって膀胱癌細胞の悪性度が増強する(発表・討論,総会賞応募ポスター,第98回日本泌尿器科学総会)

山本 勇人, 畠山 真吾, 坪井 滋, 齋藤 久夫, 山谷 金光, 舟生 富寿, 大山 力, 堀川 洋平, 羽渕 友則

日本泌尿器科学会雑誌   101 ( 2 )   2010

[Multiple inflammatory pseudotumor of the paranephric fat].

Hayato Yamamoto, Yuichiro Suzuki, Naoki Sugiyama, Akiko Okamoto, Shingo Hatakeyama, Ikuya Iwabuchi, Takahiro Yoneyama, Takuya Koie, Yasuhiro Hashimoto, Akishi Momose, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   55 ( 12 )   757 - 759   2009.12

[Multiple inflammatory pseudotumor of the paranephric fat].

Yamamoto H, Suzuki Y, Sugiyama N, Okamoto A, Hatakeyama S, Iwabuchi I, Yoneyama T, Koie T, Hashimoto Y, Momose A, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   55 ( 12 )   757 - 9   2009.12

[Solitary fibrous tumor of the kidney: a case report].

Takahiro Yoneyama, Takuya Koie, Hayato Yamamoto, Akiko Okamoto, Atsushi Imai, Ikuya Iwabuchi, Yasuhiro Hashimoto, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   55 ( 8 )   479 - 481   2009.8

[Solitary fibrous tumor of the kidney: a case report].

Yoneyama T, Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Hashimoto Y, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   55 ( 8 )   479 - 81   2009.8

[Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure].

Takuya Koie, Hayato Yamamoto, Akiko Okamoto, Atsushi Imai, Ikuya Iwabuchi, Takahiro Yoneyama, Yasuhiro Hashimoto, Akishi Momose, Noritaka Kamimura, Chikara Ohyama

Hinyokika kiyo. Acta urologica Japonica   55 ( 2 )   75 - 78   2009.2

[Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure].

Koie T, Yamamoto H, Okamoto A, Imai A, Iwabuchi I, Yoneyama T, Hashimoto Y, Momose A, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   55 ( 2 )   75 - 8   2009.2

Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.

Akiko Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Ikuya Iwabuchi, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Kazuyuki Mori, Kanemitsu Yamaya, Chikara Ohyama

Oncology reports   21 ( 1 )   73 - 79   2009.1

Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.

Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C

Oncology reports   21 ( 1 )   73 - 9   2009.1

APP-038-PM 筋層浸潤膀胱癌に対するゲムシタビン+カルボプラチンによる術前化学療法の有用性(総会賞応募ポスター,第97回日本泌尿器科学会総会)

古家 琢也, 盛 和行, 神村 典孝, 大山 力, 山本 勇人, 岡本 亜希子, 百瀬 昭志, 今井 篤, 畠山 真吾, 岩渕 郁哉, 米山 高弘, 橋本 安弘

日本泌尿器科学会雑誌   100 ( 2 )   2009

PP-633 ミニマム創内視鏡下前立腺全摘術における術前,術中自己血貯血の有用性(前立腺腫瘍/ミニマム創手術・HIFU,一般演題ポスター,第97回日本泌尿器科学会総会)

山本 勇人, 櫛方 哲也, 廣田 和美, 玉井 佳子, 岡本 亜希子, 百瀬 昭志, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 古家 琢也, 神村 典孝, 大山 力

日本泌尿器科学会雑誌   100 ( 2 )   2009

PP-444 High risk前立腺癌に対するLHRH+エストラムスチンのネオアジュバント療法+根治的前立腺全摘除術の有用性(前立腺腫瘍/薬物療法2,一般演題ポスター,第97回日本泌尿器科学会総会)

岡本 亜希子, 古家 琢也, 神村 典孝, 大山 力, 山本 勇人, 百瀬 昭志, 今井 篤, 畠山 真吾, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 盛 和行

日本泌尿器科学会雑誌   100 ( 2 )   2009

OP-194 ナフトピジル抵抗性夜間頻尿に対するプロピベリン併用の検討(BPH/Male LUTS 3,一般演題口演,第97回日本泌尿器科学会総会)

神村 典孝, 百瀬 昭志, 今井 篤, 岡本 亜希子, 山本 勇人, 大山 力, 川口 俊明, 小笠原 賢, 高橋 伸也, 高橋 淳, 吉川 和暁, 工藤 茂将, 楠美 康夫

日本泌尿器科学会雑誌   100 ( 2 )   2009

OP-163 当科におけるBCG上部尿路灌流療法の治療成績(腎盂・尿管腫瘍/臨床1,一般演題口演,第97回日本泌尿器科学会総会)

米山 高弘, 古家 琢也, 神村 典孝, 大山 力, 山本 勇人, 岡本 亜希子, 今井 篤, 畠山 真吾, 岩渕 郁哉, 橋本 安弘, 百瀬 昭志, 盛 和行

日本泌尿器科学会雑誌   100 ( 2 )   2009

OP-044 原発性アルドステロン症に対する腹腔鏡手術の降圧効果(副腎・後腹膜,一般演題口演,第97回日本泌尿器科学会総会)

橋本 安弘, 大山 力, 二川原 健, 崎原 哲, 須田 俊宏, 岡本 亜希子, 山本 勇人, 今井 篤, 岩渕 郁哉, 米山 高弘, 古家 琢也, 盛 和行, 百瀬 昭志

日本泌尿器科学会雑誌   100 ( 2 )   2009

OP-028 透析患者における掻痒症と皮膚aquaporinとの関係について(腎不全/透析1,一般演題口演,第97回日本泌尿器科学会総会)

百瀬 昭志, 岩渕 郁哉, 古家 琢也, 神村 典孝, 大山 力, 尹 重浩, 斎藤 久夫, 三國 恒靖, 舟生 富寿, 山本 勇人, 岡本 亜希子, 畠山 真吾, 今井 篤

日本泌尿器科学会雑誌   100 ( 2 )   2009

APP-092-AM 下部尿路症状の危険因子としての馬尾症状の重要性 : 住民健診レベルでの検討(総会賞応募ポスター,第97回日本泌尿器科学会総会)

今井 篤, 神村 典孝, 百瀬 昭志, 大山 力, 岡本 亜希子, 山本 勇人, 畠山 真吾, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 盛 和行, 古家 琢也

日本泌尿器科学会雑誌   100 ( 2 )   2009

APP-006 前立腺マッサージ後尿(VB3)を用いたSELDl-TOF MSによる前立腺癌のバイオマーカー検索(前立腺癌/診断・マーカー・統計,総会賞応募ポスター,第96回日本泌尿器科学会総会)

岡本 亜希子, 大山 力, 神村 典孝, 古家 琢也, 橋本 安弘, 米山 高弘, 岩渕 郁哉, 盛 和行, 今井 篤, 山本 勇人

日本泌尿器科学会雑誌   99 ( 2 )   2008

PP-337 ミニマム創膀胱全摘除術における創閉鎖法の工夫(感染症/尿道、前立腺、性器2/膀胱・腎,一般演題ポスター,第96回日本泌尿器科学会総会)

米山 高弘, 大山 力, 山本 勇人, 岡本 亜希子, 今井 篤, 岩淵 郁哉, 盛 和行, 橋本 安弘, 古家 琢也, 神村 典孝

日本泌尿器科学会雑誌   99 ( 2 )   2008

PP-233 腎孟・尿管癌術後の下部尿路再発に関する検討(腎盂・尿管腫瘍/臨床2,一般演題ポスター,第96回日本泌尿器科学会総会)

岩淵 郁哉, 大山 力, 山本 勇人, 岡本 亜希子, 今井 篤, 米山 高弘, 橋本 安弘, 盛 和行, 古家 琢也, 神村 典孝

日本泌尿器科学会雑誌   99 ( 2 )   2008

PD4-2 弘前大学におけるミニマム創手術の現況および導入に向けての提言(2008年4月、前立腺癌の治療は腹腔鏡下とミニマム創どちらがより普及しているか?,第96回日本泌尿器科学会総会)

古家 琢也, 山本 勇人, 岡本 亜希子, 今井 篤, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 神村 典孝, 大山 力

日本泌尿器科学会雑誌   99 ( 2 )   2008

APP-116 脈波伝播速度はEDの危険因子である : 住民健診におけるEDの有病率と危険因子に関する検討(アンドロロジー・不妊・性機能,総会賞応募ポスター,第96回日本泌尿器科学会総会)

今井 篤, 大山 力, 山本 勇人, 岡本 亜希子, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 盛 和行, 古家 琢也, 神村 典孝

日本泌尿器科学会雑誌   99 ( 2 )   2008

APP-095 ヒト組み換えMnSOD授与はラット腎阻血再灌流モデルの組織傷害を軽減する(腎不全・腎移植・小児泌尿器科・その他,総会賞応募ポスター,第96回日本泌尿器科学会総会)

盛 和行, 神村 典孝, 高橋 信好, 大山 力, ナイーム ラーマン, 山本 勇人, 岡本 亜希子, 今井 篤, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 古家 琢也

日本泌尿器科学会雑誌   99 ( 2 )   2008

APP-086 進行性腎細胞癌の予後因子としてのLDHとコリンエステラーゼの有用性(副腎腫瘍・腎腫瘍/マーカー・臨床,総会賞応募ポスター,第96回日本泌尿器科学会総会)

神村 典孝, 大山 力, 山本 勇人, 岡本 亜希子, 今井 篤, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 古家 琢也, 大和 隆

日本泌尿器科学会雑誌   99 ( 2 )   2008

APP-036 女性に対して施行したU字回腸新膀胱の手術成績と下部尿路機能(尿路上皮腫瘍・精巣腫瘍/臨床,尿路上皮腫瘍・精巣腫瘍/基礎,総会賞応募ポスター,第96回日本泌尿器科学会総会)

古家 琢也, 岡本 亜希子, 山本 勇人, 今井 篤, 岩渕 郁哉, 米山 高弘, 橋本 安弘, 神村 典孝, 大山 力

日本泌尿器科学会雑誌   99 ( 2 )   2008

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study)

Kyo Togashi

Urologic oncology   0201.3